A gene marker panel covering the Wnt and the Ras-Raf-MEK-MAPK signalling pathways allows to detect gene mutations in 80% of early (UICC I) colon cancer stages in humans.

doi:10.1016/j.canep.2009.05.001

Article

A gene marker panel covering the Wnt and the Ras-Raf-MEK-MAPK signalling pathways allows to detect gene mutations in 80% of early (UICC I) colon cancer stages in humans.

Cancer epidemiology - 1 Aug 2009

Scholtka Bettina, Schneider Mandy, Melcher Ralph, Katzenberger Tiemo, Friedrich Daniela, Berghof-Jäger Kornelia, Scheppach Wolfgang, Steinberg Pablo

Abstract excerpt

BACKGROUND: Very recently a gene marker panel that allows the mutational analysis of APC, CTNNB1, B-RAF and K-RAS was conceived. The aim of the present study was to use the 4-gene marker panel covering the Wnt and Ras-Raf-MEK-MAPK signalling pathways to determine the percentage of sporadic colorectal carcinomas (CRC) carrying at least one of the four above-mentioned genes in a mutated form alone and/or in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

A gene marker panel covering the Wnt and the Ras-Raf-MEK-MAPK signalling pathways allows to detect gene mutations in 80% of early (UICC I) colon cancer stages in humans.

Abstract excerpt

Topics

Related research